WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 3:02 pm Sale |
2022-12-30 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
WELLINGTON MANAGEMENT CO LLP | 31,830 0.190% |
-1,288,965 (-97.59%) |
Filing |
| 2022-02-04 09:29 am Purchase |
2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
WELLINGTON MANAGEMENT CO LLP | 1,320,795 7.730% |
404,903 (+44.21%) |
Filing |
| 2021-02-04 11:31 am Sale |
2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
WELLINGTON MANAGEMENT CO LLP | 915,892 5.920% |
-41,254 (-4.31%) |
Filing |